Table 3.
Recipient demographics and clinical outcome.
| Recipient characteristics | |
|---|---|
| Age [y, median (min–max)] | 58 (19–73) |
| Sex [N (%)] | |
| Male | 26 (74%) |
| Female | 9 (26%) |
| BMI [kg m−2, median (IQR)] | 25.50 (17.20–39.90) |
| MELD at the time of transplantation [median (IQR)] | 15.50 (6.00–33.00) |
| Outcome | |
| 1-year patient survival (benchmarking cases) | 16 (100%) |
| 1-year graft survival (benchmarking cases) | 16 (100%) |
| 1-year patient survival (total) | 28 (80%) |
| 1-year graft survival (total) | 26 (74%) |
| L-GrAFT [median (IQR)] | −0.83 (−2.39–3.13) |
| MEAF [median (IQR)] | 4.67 (1.86–8.9) |
| EAD [N (%)] | 13 (37%) |